AMPK signaling in cancer: dual roles, molecular mechanisms, and therapeutic potential

Miribane Dërmaku-Sopjani1, Rifat Morina2, Faton Sermaxhaj3

  • 1Department of Chemistry, University of Prishtina, Prishtina, Republic of Kosovo.

Abstract

Insights

Adenosine monophosphate-activated protein kinase (AMPK) regulates cellular energy. This review explores AMPK's complex roles in cancer, acting as both a tumor suppressor and promoter depending on the context.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Adenosine monophosphate-activated protein kinase (AMPK) is a key regulator of cellular energy homeostasis.
  • Dysregulation of AMPK signaling is implicated in various malignancies due to cancer cells' altered metabolic demands.
  • Understanding AMPK's multifaceted roles is crucial for cancer research.

Purpose of the Study:

  • To review recent advancements in understanding the dual roles of AMPK in tumor progression and suppression.
  • To synthesize current knowledge on how AMPK signaling impacts cancer development.
  • To explore AMPK's involvement in metabolic reprogramming within cancer cells.

Main Methods:

  • Systematic literature search of PubMed, Scopus, and Web of Science databases.
  • Focus on research published between 2010 and 2025.
  • Utilized relevant keywords to identify pertinent studies on AMPK and cancer.

Main Results:

  • AMPK influences oncogenic signaling pathways, including mTORC1, p53, and FOXO, in a context-dependent manner.
  • AMPK primarily acts as a tumor suppressor in early carcinogenesis but can promote cancer cell survival in specific tumor contexts.
  • The effect of AMPK on cancer progression is variable, inhibiting or enhancing it based on cell type and condition.

Conclusions:

  • AMPK exhibits a dual role in cancer, acting as both a suppressor and promoter.
  • AMPK's modulation of metabolic pathways makes it a potential therapeutic target in precision oncology.
  • Further research into AMPK's context-specific functions is warranted for targeted cancer therapies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...